Your browser doesn't support javascript.
loading
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Jansen, Willemijn J; Ossenkoppele, Rik; Knol, Dirk L; Tijms, Betty M; Scheltens, Philip; Verhey, Frans R J; Visser, Pieter Jelle; Aalten, Pauline; Aarsland, Dag; Alcolea, Daniel; Alexander, Myriam; Almdahl, Ina S; Arnold, Steven E; Baldeiras, Inês; Barthel, Henryk; van Berckel, Bart N M; Bibeau, Kristen; Blennow, Kaj; Brooks, David J; van Buchem, Mark A; Camus, Vincent; Cavedo, Enrica; Chen, Kewei; Chetelat, Gael; Cohen, Ann D; Drzezga, Alexander; Engelborghs, Sebastiaan; Fagan, Anne M; Fladby, Tormod; Fleisher, Adam S; van der Flier, Wiesje M; Ford, Lisa; Förster, Stefan; Fortea, Juan; Foskett, Nadia; Frederiksen, Kristian S; Freund-Levi, Yvonne; Frisoni, Giovanni B; Froelich, Lutz; Gabryelewicz, Tomasz; Gill, Kiran Dip; Gkatzima, Olymbia; Gómez-Tortosa, Estrella; Gordon, Mark Forrest; Grimmer, Timo; Hampel, Harald; Hausner, Lucrezia; Hellwig, Sabine; Herukka, Sanna-Kaisa; Hildebrandt, Helmut.
Afiliación
  • Jansen WJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.
  • Ossenkoppele R; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands3Department of Radiology and Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the.
  • Knol DL; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Tijms BM; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
  • Scheltens P; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
  • Verhey FR; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.
  • Visser PJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands2Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience.
  • Aalten P; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.
  • Aarsland D; Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Alcolea D; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Alexander M; Roche Products, Welwyn Garden City, United Kingdom.
  • Almdahl IS; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Arnold SE; Department of Neurology, University of Pennsylvania, Philadelphia.
  • Baldeiras I; Center for Neuroscience and Cell Biology, Faculty of Medicine, Hospital Center University of Coimbra, Portugal.
  • Barthel H; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
  • van Berckel BN; Department of Radiology and Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
  • Bibeau K; GlaxoSmithKline, Worldwide Epidemiology, Research Triangle Park, North Carolina.
  • Blennow K; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
  • Brooks DJ; Division of Neuroscience, Medical Research Council Clinical Sciences Centre, Imperial College London, London, United Kingdom.
  • van Buchem MA; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Camus V; CHRU de Tours, CIC INSERM 1415, INSERM U930, and Université François Rabelais de Tours, Tours, France.
  • Cavedo E; Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy20Sorbonne University, University Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) and Institut.
  • Chen K; Banner Alzheimer's Institute, Phoenix, Arizona.
  • Chetelat G; Institut National de la Santé et de la Recherche Médicale (Inserm), U1077, Caen, France.
  • Cohen AD; University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, Pennsylvania.
  • Drzezga A; Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
  • Engelborghs S; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium.
  • Fagan AM; Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St Louis, Missouri.
  • Fladby T; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Fleisher AS; Banner Alzheimer's Institute, Phoenix, Arizona27Eli Lilly, Indianapolis, Indiana28Department of Neurosciences, University of California, San Diego.
  • van der Flier WM; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands6Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Ford L; Janssen Research and Development, Titusville, New Jersey.
  • Förster S; Department of Nuclear Medicine, Technischen Universitaet München, Munich, Germany.
  • Fortea J; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Foskett N; Roche Products, Welwyn Garden City, United Kingdom.
  • Frederiksen KS; Danish Dementia Research Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
  • Freund-Levi Y; Department of Geriatrics, Institution of NVS, Section of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.
  • Frisoni GB; Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy88Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals, and University of Geneva, Geneva, Switzerland.
  • Froelich L; Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Gabryelewicz T; Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland.
  • Gill KD; Postgraduate Institute of Medical Education and Research (PGIMER), Department of Biochemistry, Research Block-A, Chandigarh, India.
  • Gkatzima O; Third Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Gómez-Tortosa E; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
  • Gordon MF; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut.
  • Grimmer T; Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitaet München, Munich, Germany.
  • Hampel H; AXA Research Fund and UPMC ChairSorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer and INSERM U1127, Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital.
  • Hausner L; Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Hellwig S; Center of Geriatrics and Gerontology, University Hospital Freiburg, Freiburg, Germany.
  • Herukka SK; Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Hildebrandt H; Center for Neurology, Hospital of Bremen-Ost, Bremen, Germany.
JAMA ; 313(19): 1924-38, 2015 May 19.
Article en En | MEDLINE | ID: mdl-25988462
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Péptidos beta-Amiloides / Apolipoproteína E4 / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Péptidos beta-Amiloides / Apolipoproteína E4 / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos